Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Rhythm Pharmaceuticals Inc
(NQ:
RYTM
)
33.21
USD
+2.10 (+6.75%)
Streaming Delayed Price
Updated: 11:06 AM EST, Jan 28, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Rhythm Pharmaceuticals Inc
< Previous
1
2
3
4
5
6
7
Next >
The Daily Biotech Pulse: Sorrento, Immutep Surge On COVID-19 Study Data, T2 Biosystems Sinks On Preannouncement
January 27, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Tags
CLPT
INSM
SRNE
From
Benzinga
Why Is It Moving? Looking Into Why Rhythm Pharmaceuticals's Stock is Trading Higher Today
January 26, 2021
The Price And Volume Action In Rhythm Pharmaceuticals's Stock Today Rhythm Pharmaceuticals's (NASDAQ:RYTM) stock is trading ...
Tags
Benzinga
RYTM
Trading Ideas
From
Benzinga
Stocks That Hit 52-Week Highs On Tuesday
January 26, 2021
This morning 163 companies set new 52-week highs. Areas of Significance: The largest company by market cap ...
Tags
LUMN
NNDM
MDCA
From
Benzinga
The Daily Biotech Pulse: Novartis Misses, J&J Beats In Big Pharma Earnings, Vaccine Developer CureVac Taps Equity Market
January 26, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
RYTM
SUPN
EXAS
From
Benzinga
Rhythm Pharmaceuticals Announces Positive Data with Setmelanotide in Additional MC4R Pathway Deficiency-related Obesities
January 26, 2021
From
GlobeNewswire News Releases
Stocks That Hit 52-Week Highs On Monday
January 25, 2021
During the morning session on Monday, 372 stocks hit new 52-week highs. Highlights: Apple (NASDAQ:AAPL) was ...
Tags
NARI
Intraday Update
Trading Ideas
From
Benzinga
RYTM Crosses Above Average Analyst Target
January 25, 2021
In recent trading, shares of Rhythm Pharmaceuticals Inc (RYTM) have crossed above the average analyst 12-month target price of $37.00, changing hands for $39.49/share. When a stock reaches the target...
Tags
ETFs
From
ETF Channel
The Week Ahead In Biotech (Jan 24-30): J&J, Lilly to Kickstart Big Pharma Earnings, Amgen FDA Decision and More
January 23, 2021
Biopharma stocks advanced yet again in the week ended Jan. 22, with the change of guard at the White House generating broader market ...
Tags
RYTM
ABMD
JNJ
From
Benzinga
Stocks That Hit 52-Week Highs On Friday
January 22, 2021
Before 10 a.m. ET Friday, 82 stocks hit new 52-week highs. Areas of Interest: PayPal Holdings (NASDAQ:PYPL) ...
Tags
LYTS
FPI
CVLB
From
Benzinga
The Daily Biotech Pulse: Fluidigm's Saliva-Based COVID Test Approved In Europe, China Backs Amarin's Vascepa
January 22, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Tags
News
AUPH
GSK
From
Benzinga
Stocks That Hit 52-Week Highs On Thursday
January 21, 2021
During Thursday's morning trading, 190 companies set new 52-week highs. Areas of Interest: Alphabet (NASDAQ:GOOG) ...
Tags
TTGT
TMHC
SLAB
From
Benzinga
The Daily Biotech Pulse: Addex Jumps On Positive Data For Out-Licensed Drug, COVID-19 Vaccine Developer Inovio Announces $150M Follow-On Offering, Boston Scientific Goes Shopping
January 21, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
LMAT
INMB
SUPN
From
Benzinga
Rhythm Pharmaceuticals to Provide Update on Phase 2 Basket Study and Genetic Sequencing Efforts
January 19, 2021
From
GlobeNewswire News Releases
The Daily Biotech Pulse: Sarepta Gene Therapy Study Readout, Novavax Vaccine Supply Deal, 2 IPOs
January 08, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Tags
RYTM
RCKT
LMAT
From
Benzinga
Rhythm Pharmaceuticals Announces Sale of Priority Review Voucher for $100M
January 05, 2021
From
GlobeNewswire News Releases
Pharvaris Expands Board of Directors with Appointment of David Meeker, M.D., as Chair and Robert Glassman, M.D., as Director
January 05, 2021
Pharvaris, a clinical-stage company focused on the discovery and development of novel oral bradykinin-B2-receptor antagonists for the treatment of hereditary angioedema (HAE) and other...
From
PR Newswire
Rhythm Pharmaceuticals Announces Positive Topline Results from Pivotal Phase 3 Clinical Trial Evaluating Setmelanotide in Bardet-Biedl and Alström Syndromes
December 22, 2020
From
GlobeNewswire News Releases
Rhythm Pharmaceuticals Announces Appointments of Camille L. Bedrosian, M.D., and Lynn Tetrault, J.D., to its Board of Directors
December 11, 2020
From
GlobeNewswire News Releases
12 Healthcare Stocks Moving In Thursday's Intraday Session
December 03, 2020
Gainers Iterum Therapeutics (NASDAQ:ITRM) shares rose 39.67% to $0.91 during Thursday's regular session. As of 12:32 ...
Tags
SXTC
AIKI
healthcare stocks
From
Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech Vaccine Gets Temporary UK Authorization, Ovid's Trial Disappointment, Vanda Snags FDA Nod
December 02, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Tags
GBIO
CRSP
SYNH
From
Benzinga
Stocks That Hit 52-Week Highs On Tuesday
December 01, 2020
Tuesday's morning session saw 195 companies set new 52-week highs. Areas of Significance: The largest company by ...
Tags
RMT
GWPH
ASML
From
Benzinga
Benzinga's Top Upgrades, Downgrades For November 30, 2020
November 30, 2020
Upgrades B of A Securities upgraded the previous rating for Ventas Inc (NYSE: VTR) from Underperform to Buy. For the third ...
Tags
ROK
SYF
PTCT
From
Benzinga
64 Biggest Movers From Friday
November 30, 2020
Gainers SCWorx Corp. (NASDAQ: WORX) shares climbed 77.6% to close at $2.22 on Friday on more than 4x average volume. The ...
Tags
GIK
LWAY
THCB
From
Benzinga
How This Small Biotech Is Targeting Obesity — And Why Shares Are Surging
November 27, 2020
Rhythm Pharmaceuticals gained Food and Drug Administration approval for an obesity drug for patients with rare genetic deficiencies, and RYTM stock rocketed to a two-month high.
From
Investor's Business Daily
12 Healthcare Stocks Moving In Friday's Intraday Session
November 27, 2020
Gainers SCWorx (NASDAQ:WORX) stock rose 75.94% to $2.2 during Friday's regular session. Trading volume for ...
Tags
Intraday Update
WORX
Markets
From
Benzinga
Mid-Day Market Update: Nasdaq Surges 100 Points; Sorrento Therapeutics Shares Spike Higher
November 27, 2020
Midway through trading Friday, the Dow traded up 0.04% to 29,883.70 while the NASDAQ rose 0.86% to 12,197.94. The S&P also rose, ...
Tags
News
SRNE
RYTM
From
Benzinga
48 Stocks Moving In Friday's Mid-Day Session
November 27, 2020
Gainers SCWorx Corp. (NASDAQ: WORX) shares jumped 79.2% to $2.24 on more than 4x average volume. The company’s shares gained ...
Tags
Packaged Foods & Meats
COCP
VSTM
From
Benzinga
Mid-Morning Market Update: Markets Open Higher; Disney Laying Off 32,000 Workers
November 27, 2020
Following the market opening Friday, the Dow traded up 0.29% to 29,958.11 while the NASDAQ rose 0.86% to 12,198.84. The S&P also ...
Tags
Market News
VSTM
FTFT
From
Benzinga
12 Healthcare Stocks Moving In Friday's Pre-Market Session
November 27, 2020
Gainers SCWorx (NASDAQ:WORX) stock moved upwards by 103.99% to $2.55 during Friday's pre-market session. The market ...
Tags
ATNF
TYME
Top Gainers
From
Benzinga
Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE™ (setmelanotide) as First-ever Therapy for Chronic Weight Management in Patients with Obesity Due to POMC, PCSK1 or LEPR Deficiency
November 27, 2020
From
GlobeNewswire News Releases
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.